Top Markets
#1 Siacoin Siacoin +40.73%
#2 The Bitcoin Bull The Bitcoin Bull +30.97%
#3 DogBull DogBull +26.76%
#4 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#5 Cash Cat Cash Cat +24.61%
#6 Cryptopia Cryptopia +11.07%
#7 Akedo Akedo +8.67%
#8 Pons Pons +8.64%
#9 DMT-NAT DMT-NAT +8.49%
#10 Helium Helium +8.03%
Coin of the day
Siacoin Siacoin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Kedudukan dalam Saham #13846
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Harga Saham
$4.36
Disegerakkan terakhir: 2026-08-31
Modal Pasaran
$457.32M
Perubahan (1 hari)
0.69%
Perubahan (1 tahun)
289.29%
Negara
US
Perdagangan Relmada Therapeutics, Inc. (RLMD)

Kategori

Healthcare
Pendapatan untuk Relmada Therapeutics, Inc. (RLMD)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Relmada Therapeutics, Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Relmada Therapeutics, Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH